Skip to content
Delayed ~15 min

CAPR CAPRICOR THERAPEUTICS

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Tue 10 Nov 2026 · after market close

What 14 analyst firms say about CAPRICOR THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works

9.00 USD+0.40 (+4.65%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+233.3%to the avg target 30.00 USD+21.00 USD
Buy 4 · Hold 7 · Sell 0

11 rated views · 14 analyst/firm records · 14 firms

Latest report14 Sep 2026avg report date 16 Jun
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8021
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8015

Recent analyst activity · last 90 days

Our tracked history has 7 reports on CAPR from 5 analyst firms in the last 90 days (14 firms in the past year).

Comparing each firm's latest target with its previous one: 2 raised their price target and 2 left it unchanged.

Ratings, latest available report against the previous one: 2 upgrades and 0 downgrades.

Latest observed target change: B. Riley Securities raised its target from $10.00 (set 27 Jul 2026) to $21.00 on 13 Sep 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Alliance Global PartnersMatthew VeneziaHold28 Jul 20267.00 USD
B Riley SecuritiesMadison El-SaadiBuy14 Sep 202621.00 USD
Cantor FitzgeraldKristen KluskaBuy14 Aug 202628.00 USD
H.C. WainwrightJoseph PantginisHold30 Jul 2026—
Ia FinancialUnnamed analyst—3 Dec 202548.00 USD
JonestradingCatherine NovackHold31 Jul 2026—
Ladenburg ThalmannRick BienkowskiHold30 Jul 2026—
Maxim GroupJason MccarthyHold30 Jul 2026—
OppenheimerUnnamed analystBuy8 Oct 202654.00 USD · 25 Aug 2026
Piper SandlerEdward TenthoffBuy1 Sep 202625.00 USD
Roth CapitalBoobalan PachaiyappanHold27 Jul 20267.00 USD
UBSUnnamed analyst—15 Dec 202550.00 USD
Weiss RatingsUnnamed analyst—11 Sep 2026—
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:11 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.